GeneralConnection.com ➔ Dictionary
Dictionary Search

melphalan

Synonyms

Noun

1. Alkeran

2. antineoplastic, antineoplastic drug, cancer drug

Usage
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma - Nature
Pegargiminase Suppresses the Fanconi Anemia Pathway and Promotes Melphalan-Induced DNA Double-Strand Breaks in Uveal Melanoma - Wiley Online Library
Melphalan/Hepatic Delivery System Displays Efficacy in Uveal Melanoma - CancerNetwork
Is Less “Sufficient” and “Safe” in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma | Blood Cancer Journal - Nature
MSK Highlights Advances in Transplant and Cellular Therapy at Tandem Meetings - Memorial Sloan Kettering Cancer Center
Outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis - Wiley
How Does Melphalan Treat Uveal Melanoma That Spreads to the Liver? - City of Hope
Thalidomide as a rescue protocol for treatment of multiple myeloma in dogs: preliminary data from a multicentre retrospective study - Frontiers
Can the Melphalan Rest Day Before Stem Cell Infusion Be Safely Eliminated? - Cancer Nursing Today
Multiple myeloma after CAR T: TP53-mutant clonal hematopoiesis flags early AML and MDS risk - Vera Health
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma - The New England Journal of Medicine
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party - Haematologica
Intra-arterial Melphalan as Targeted Therapy for Tumefactive Multiple Sclerosis Lesions - Neurology® Journals
Antiemetic Regimen Limits Chemo-Induced Nausea/Vomiting in Multiple Myeloma - CancerNetwork
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis | Bone Marrow Transplantation - Nature
Immunoembolization in liver-predominant metastatic uveal melanoma: a single-center retrospective analysis - Frontiers
Ice-cream used as cryotherapy during high-dose melphalan conditioning reduces oral mucositis after autologous hematopoietic stem cell transplantation - Nature
PNMA1 mediates melphalam chemoresistance in retinoblastoma via promoting DNA repair - Nature
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect | Bone Marrow Transplantation - Nature
Outcomes of attenuated dose fludarabine and melphalan based conditioning regimen in patients undergoing allogeneic stem cell transplant: a propensity score-matched analysis | Bone Marrow Transplantation - Nature
Melphalan Flufenamide Withdrawn From US Market Following Discourse With FDA - CancerNetwork
Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual disease - Nature
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison | Bone Marrow Transplantation - Nature
Novel environmental and sustainable approach for concurrent assay of antineoplastics in VMP regimen with a comprehensive Pharmacokinetic study - Nature
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma - The New England Journal of Medicine
Curcumin and melphalan cotreatment induces cell cycle arrest and apoptosis in MDA-MB-231 breast cancer cells - Nature
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis - The New England Journal of Medicine
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working P - Nature
The mutagenic impact of melphalan in multiple myeloma - Nature
Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells - Nature
Navigating hair loss, and regrowth, after SCT for multiple myeloma - Rare Cancer News
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT | Bone M - Nature
Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma - The ASCO Post
FDA Approves Melphalan Hepatic Delivery System for Adult Patients With Unresectable Hepatic-Dominant Metastatic Uveal Melanoma - The ASCO Post
Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial - Nature
FDA Confirms Decision to Withdraw Melphalan Flufenamide Approval in Multiple Myeloma - OncLive
Melphalan-Based Liver-Directed Therapy for Metastatic Uveal Melanoma - The ASCO Post
High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumors - Nature
Low-Dose Melphalan Achieves Survival Outcomes, Relapse Rates Similar to Standard Dose - Oncology Nurse Advisor
Addition of High-Dose Treosulfan and Melphalan to Consolidation in High-Risk Ewing Sarcoma - The ASCO Post
What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone? - Nature
A higher throughput assay for quantification of melphalan-induced DNA damage in peripheral blood mononuclear cells - Nature
Melphalan/HDS Shows Benefit in Metastatic Uveal Melanoma - Targeted Oncology
Apotex introduces IVRA™ (Melphalan) hydrochloride injection: First ready to dilute liquid formulation of Melphalan injection approved via 505(b)(2) NDA in the United States - PR Newswire
Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party - Nature
Intravenous Busulfan Plus Melphalan vs Melphalan Alone as a Conditioning Regimen in Multiple Myeloma: Is There a Difference? - Cancer Therapy Advisor
Olanzapine versus Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting Prophylaxis in Patients Receiving Single-Day High-Dose Melphalan - Journal of Hematology Oncology Pharmacy
VisualAbstract Melphalan 200mg/m2 Versus Reduced Doses of Melphalan in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation - 2 Minute Medicine
Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status - Nature
High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy - Nature
Comparative analysis of reduced toxicity conditioning regimens between fludarabine plus melphalan and fludarabine plus busulfex in adult patients with acute lymphoblastic leukemia | Bone Marrow Transplantation - Nature
Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma - Nature
Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation - Nature
High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma - Nature
Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients - Nature
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma - The New England Journal of Medicine
Monoclonal gammopathy of clinical significance in a young patient treated with melphalan-thalidomide-prednisone - Wiley Online Library
Jonathan S. Zager, MD, Reviews Percutaneous Hepatic Perfusion With Melphalan in Ocular Melanoma With Hepatic Metastases - CancerNetwork
Generic melphalan available in US - MDEdge
A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine - The New England Journal of Medicine
Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis - Nature
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma - The New England Journal of Medicine
An elective single autograft with high-dose melphalan: single-center study of 451 patients - Nature
A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis - Nature
Intravitreal melphalan may control retinoblastoma seeds - 2 Minute Medicine
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Par - Nature
Scalp Cooling During Transplantation for Myeloma: Is Hair Loss Avoidable? - CancerNetwork
FDA OKs First Liver-Directed Treatment for Metastatic Uveal Melanoma - MedPage Today
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation - Nature
Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases - Frontiers
Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis - Nature
A Single Surviving Myeloma Cell Can Seed Accelerated Relapse - Memorial Sloan Kettering Cancer Center
Shorter Duration of Cryotherapy as Effective as Standard Therapy Prior to HSCT for Multiple Myeloma - Oncology Nurse Advisor
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02 - The Lancet
A Case of Severe Hemorrhagic Cystitis Caused by Melphalan with Successful Bladder Preservation by Ligation of Bilateral Internal Iliac Arteries - Wiley Online Library
Role of isolated limb perfusion with recombinant human tumor necrosis factor α and melphalan in locally advanced extremity soft tissue sarcoma - Wiley
Busulfan and cyclophosphamide for autologous stem cell transplantation in patients with multiple myeloma after proteasome inhibitor and/or immunomodulatory drug treatment - Nature
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma - Nature
Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model - Nature
Intravitreal Chemotherapy for Retinoblastoma: Promising but Controversial - American Academy of Ophthalmology
PEPAXTO® (melphalan flufenamide) for the Treatment of Multiple Myeloma - Clinical Trials Arena
Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect - Nature
Day Of Rest Between Melphalan And Stem Cell Infusion May Not Be Necessary For Myeloma Patients - The Myeloma Beacon
Lenalidomide−prednisone induction followed by lenalidomide−melphalan−prednisone consolidation and lenalidomide−prednisone maintenance in newly diagnosed elderly unfit myeloma patients - Nature
Potential mechanism for myeloma drug’s variable toxicity - Vanderbilt Health News
Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma - Springer Nature Link
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan - Nature
New liver directed treatment improves outcomes for rare eye cancer - News-Medical
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia - Wiley Online Library
Melphalan induced germ cell toxicity and dose-dependent effects of β-aminoisobutyric acid in experimental rat model: Role of oxidative stress, inflammation and apoptosis - Wiley Online Library
High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease - Nature
Novel Drug Device Combination May Improve Outcomes in Metastatic Uveal Melanoma - The ASCO Post
Addition of Daratumumab to Treatment Regimen in Transplant-Ineligible Newly Diagnosed Multiple Myeloma - The ASCO Post
Daratumumab Approved as Frontline Treatment in Newly Diagnosed Multiple Myeloma - AJMC
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft - Nature
Autologous stem cell transplantation is safe and effective for fit, older myeloma patients - Haematologica
Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma - The New England Journal of Medicine
Pre-transplant regimen for autologous SCT in AML patients in CR1 – Busulfan and melphalan or busulfan and cyclophosphamide - aml-hub.com
Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis - Nature
Second Primary Malignancies Explored in Multiple Myeloma - The ASCO Post
Foreign Language Equivalents
Foreign Language Equivalents of 'melphalan'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
melphlaan,   elphalan,   melhalan,   mrlphalan,   melpalan,   melpgalan,   mmelphalan,   melphalam,   melphalann,   melphala,   melphaln,   melphalna,   melpahlan,   me;phalan,   emlphalan,   melphhalan,   mephalan,   melpha;an,   nelphalan,   melohalan,   melphalsn,   melphallan,   melphalaan,   melphaan,   meelphalan,   mlphalan,   ,elphalan,   meplhalan,   mel[halan,   melpphalan,   melphaaln,   mlephalan,   melphslan,   melphaalan,   mwlphalan,   mellphalan,   melhpalan,   melpjalan,   melphalab,   melphakan,   melphlan,   mekphalan
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z